Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation

Journal of the American College of Cardiology

Volumn 69, Issue 18, 2017, Pages 2331-2341

  Chang, James D ^a   Manning, Warren J ^a   Ebrille, Elisa ^a   Zimetbaum, Peter J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

echocardiography; heart failure; implantable defibrillators; regurgitation; transvenous lead extraction; tricuspid valve insufficiency

Indexed keywords

DEATH; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; HEART FAILURE; HEART PACING; HEMODYNAMICS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MITRAL ANNULOPLASTY; MORBIDITY; REVIEW; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; ADVERSE EFFECTS; ANATOMY AND HISTOLOGY; DEVICE REMOVAL; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY;

DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; HUMANS; POSTOPERATIVE COMPLICATIONS; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY;

EID: 85018442772     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.02.055     Document Type: Review

References (118)

1. 1 Greenspon, A.J., Patel, J.D., Lau, E., et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 60 (2012), 1540–1545.
2. 2 Wood, M.A., Ellenbogen, K.A., Cardiac pacemakers from the patient's perspective. Circulation 105 (2002), 2136–2138.
3. 3 Marijon, E., Trinquart, L., Otmani, A., et al., EVADEF Investigators. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator: the EVADEF study. Am Heart J 159 (2010), 659–664.e1.
4. 4 Packer, D.L., Prutkin, J.M., Hellkamp, A.S., et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the Sudden Cardiac Death in Heart Failure trial. Circulation 120 (2009), 2170–2176.
5. 5 Goldenberg, I., Moss, A.J., Hall, W.J., et al., Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 113 (2006), 2810–2817.
6. 6 Nath, J., Foster, E., Heidenreich, P.A., Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43 (2004), 405–409.
7. 7 Mutlak, D., Aronson, D., Lessick, J., Reisner, S.A., Dabbah, S., Agmon, Y., Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?. Chest 135 (2009), 115–121.
8. 8 Paniagua, D., Aldrich, H.R., Lieberman, E.H., Lamas, G.A., Agatston, A.S., Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol 82 (1998), 1130–1132 A9.
9. 9 Delling, F.N., Hassan, Z.K., Piatkowski, G., et al. Tricuspid regurgitation and mortality in patients with transvenous permanent pacemaker leads. Am J Cardiol 117 (2016), 988–992.
10. 10 Höke, U., Auger, D., Thijssen, J., et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 100 (2014), 960–968.
11. 11 Al-Bawardy, R., Krishnaswamy, A., Rajeswaran, J., et al. Tricuspid regurgitation and implantable devices. Pacing Clin Electrophysiol 38 (2015), 259–266.
12. 12 Dilaveris, P., Pantazis, A., Giannopoulos, G., Synetos, A., Gialafos, J., Stefanadis, C., Upgrade to biventricular pacing in patients with pacing-induced heart failure: can resynchronization do the trick?. Europace 8 (2006), 352–357.
13. 13 Rogers, J.H., Bolling, S.F., The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation 119 (2009), 2718–2725.
14. 14 Gould, L., Reddy, C.V., Yacob, U., et al. Perforation of the tricuspid valve by a transvenous pacemaker. JAMA 230 (1974), 86–87.
15. 15 Rubio, P.A., al-Bassam, M.S., Pacemaker-lead puncture of the tricuspid valve: successful diagnosis and treatment. Chest 99 (1991), 1519–1520.
16. 16 Schilling, R.J., Pacing lead entanglement in the tricuspid valve apparatus during implantation. Europace, 1, 1999, 201.
17. 17 Petterson, S.R., Singh, J.B., Reeves, G., Kocot, S.L., Tricuspid valve perforation by endocardial pacing electrode. Chest 63 (1973), 125–126.
18. 18 Fishenfeld, J., Lamy, Y., Laceration of the tricuspid valve by a pacemaker wire. Chest 61 (1972), 697–698.
19. 19 Lee, M.E., Chaux, A., Matloff, J.M., Avulsion of a tricuspid valve leaflet during traction on an infected, entrapped endocardial pacemaker electrode: the role of electrode design. J Thorac Cardiovasc Surg 74 (1977), 433–435.
20. 20 Ong, L.S., Barold, S.S., Craver, W.L., Falkoff, M.D., Heinle, R.A., Partial avulsion of the tricuspid valve by tined pacing electrode. Am Heart J 102 (1981), 798–799.
21. 21 Epstein, A.E., Kay, G.N., Plumb, V.J., Dailey, S.M., Anderson, P.G., Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 98 (1998), 1517–1524.
22. 22 Christie, J.L., Keelan, M.H. Jr., Tricuspid valve perforation by a permanent pacing lead in a patient with cardiac amyloidosis: case report and brief literature review. Pacing Clin Electrophysiol 9 (1986), 124–126.
23. 23 Rajs, J., Postmortem findings and possible causes of unexpected death in patients treated with intraventricular pacing. Pacing Clin Electrophysiol 6 (1983), 751–760.
24. 24 Frandsen, F., Oxhøj, H., Nielsen, B., Entrapment of a tined pacemaker electrode in the tricuspid valve: a case report. Pacing Clin Electrophysiol 13 (1990), 1082–1083.
25. 25 Wilner, B.R., Coffey, J.O., Mitrani, R., Carrillo, R.G., Perforated tricuspid valve leaflet resulting from defibrillator leads: a review of the literature. J Card Surg 29 (2014), 470–472.
26. 26 Andreas, M., Gremmel, F., Habertheuer, A., et al. Case report: pacemaker lead perforation of a papillary muscle inducing severe tricuspid regurgitation. J Cardiothorac Surg, 10, 2015, 39.
27. 27 Moreno, R., Zamorano, J., Ortega, A., et al. Tricuspid valve chordae rupture following pacemaker electrode replacement. Int J Cardiol 87 (2003), 291–292.
28. 28 Barclay, J.L., Cross, S.J., Leslie, S.J., Entanglement of passive fix ventricular lead in tricuspid valve. Pacing Clin Electrophysiol, 31, 2008, 138.
29. 29 Friedberg, H.D., D'Cunha, G.F., Adhesions of pacing catheter to tricuspid valve: adhesive endocarditis. Thorax 24 (1969), 498–499.
30. 30 Robboy, S.J., Harthorne, J.W., Leinbach, R.C., Sanders, C.A., Austen, W.G., Autopsy findings with permanent pervenous pacemakers. Circulation 39 (1969), 495–501.
31. 31 Res, J.C., De Cock, C.C., Van Rossum, A.C., Schreuder, J., Entrapment of tined leads. Pacing Clin Electrophysiol 12 (1989), 1583–1585.
32. 32 Fürstenberg, S., Bluhm, G., Olin, C., Entrapment of an atrial tined pacemaker electrode in the tricuspid valve: a case report. Pacing Clin Electrophysiol 7 (1984), 760–762.
33. 33 Rajappan, K., Permanent pacemaker implantation technique: part II. Heart 95 (2009), 334–342.
34. 34 Lee, R.C., Friedman, S.E., Kono, A.T., Greenberg, M.L., Palac, R.T., Tricuspid regurgitation following implantation of endocardial leads: incidence and predictors. Pacing Clin Electrophysiol 38 (2015), 1267–1274.
35. 35 de Cock, C.C., Vinkers, M., Van Campe, L.C., Verhorst, P.M., Visser, C.A., Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol 23 (2000), 423–426.
36. 36 Klutstein, M., Balkin, J., Butnaru, A., Ilan, M., Lahad, A., Rosenmann, D., Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol 32:Suppl 1 (2009), S135–S137.
37. 37 Webster, G., Margossian, R., Alexander, M.E., et al. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol 21 (2008), 65–68.
38. 38 Kim, J.B., Spevack, D.M., Tunick, P.A., et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 21 (2008), 284–287.
39. 39 Al-Bawardy, R., Krishnaswamy, A., Bhargava, M., et al. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol 36 (2013), 249–254.
40. 40 Dokainish, H., Elbarasi, E., Masiero, S., et al. Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: background, rationale, and design. Glob Cardiol Sci Pract, 2015, 2015, 41.
41. 41 Seo, Y., Ishizu, T., Nakajima, H., Sekiguchi, Y., Watanabe, S., Aonuma, K., Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J 72 (2008), 1465–1470.
42. 42 Baquero, G.A., Yadav, P., Skibba, J.B., et al. Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads. J Interv Card Electrophysiol 38 (2013), 197–202.
43. 43 Postaci, N., Ekşi, K., Bayata, S., Yeşil, M., Effect of the number of ventricular leads on right ventricular hemodynamics in patients with permanent pacemaker. Angiology 46 (1995), 421–424.
44. 44 Eleid, M.F., Blauwet, L.A., Cha, Y.M., et al. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol 59 (2012), 813–818.
45. 45 Ratschiller, T., Guenther, T., Knappich, C., et al. Do transvalvular pacemaker leads influence functional outcome after tricuspid ring annuloplasty?. Eur J Cardiothorac Surg 48 (2015), 363–369.
46. 46 Stokes, K., Anderson, J., McVenes, R., McClay, C., The encapsulation of polyurethane-insulated transvenous cardiac pacemaker leads. Cardiovasc Pathol 4 (1995), 163–171.
47. 47 Candinas, R., Duru, F., Schneider, J., Lüscher, T.F., Stokes, K., Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads. Mayo Clin Proc 74 (1999), 120–125.
48. 48 Myers, M.R., Parsonnet, V., Bernstein, A.D., Extraction of implanted transvenous pacing leads: a review of a persistent clinical problem. Am Heart J 121 (1991), 881–888.
49. 49 Iskandar, S.B., Jackson, S.A., Fahrig, S., Mechleb, B.K., Garcia, I.D., Tricuspid valve malfunction and ventricular pacemaker lead: case report and review of the literature. Echocardiography 23 (2006), 692–697.
50. 50 Taira, K., Suzuki, A., Fujino, A., Watanabe, T., Ogyu, A., Ashikawa, K., Tricuspid valve stenosis related to subvalvular adhesion of pacemaker lead: a case report. J Cardiol 47 (2006), 301–306.
51. 51 Heaven, D.J., Henein, M.Y., Sutton, R., Pacemaker lead related tricuspid stenosis: a report of two cases. Heart 83 (2000), 351–352.
52. 52 Nisanci, Y., Yilmaz, E., Oncul, A., Ozsaruhan, O., Predominant tricuspid stenosis secondary to bacterial endocarditis in a patient with permanent pacemaker and balloon dilatation of the stenosis. Pacing Clin Electrophysiol 22 (1999), 393–396.
53. 53 Old, W.D., Paulsen, W., Lewis, S.A., Nixon, J.V., Pacemaker lead-induced tricuspid stenosis: diagnosis by Doppler echocardiography. Am Heart J 117 (1989), 1165–1167.
54. 54 Lin, G., Nishimura, R.A., Connolly, H.M., Dearani, J.A., Sundt, T.M. III, Hayes, D.L., Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 45 (2005), 1672–1675.
55. 55 Gibson, T.C., Davidson, R.C., DeSilvey, D.L., Presumptive tricuspid valve malfunction induced by a pacemaker lead: a case report and review of the literature. Pacing Clin Electrophysiol 3 (1980), 88–95.
56. 56 Krupa, W., Kozlowski, D., Derejko, P., Swiatecka, G., Permanent cardiac pacing and its influence on tricuspid valve function. Folia Morphol (Warsz) 60 (2001), 249–257.
57. 57 Rainer, P.P., Schmidt, A., Anelli-Monti, M., Kleinert, R., Pieske, B.M., Maier, R.M., A swinging pacemaker lead promoting endocarditis and severe tricuspid regurgitation. J Am Coll Cardiol, 59, 2012, e45.
58. 58 Belikov, S., Marijic, J., Laks, H., et al. Sepsis from insidious pacemaker infection and unsuspected tricuspid valve endocarditis: the importance of transesophageal echocardiography in guiding explantation strategy. J Cardiothorac Vasc Anesth 19 (2005), 505–507.
59. 59 Unger, P., Clevenbergh, P., Crasset, V., Selway, P., Le Clerc, J.L., Pacemaker-related endocarditis inducing tricuspid stenosis. Am Heart J 133 (1997), 605–607.
60. 60 Enia, F., Lo Mauro, R., Meschisi, F., Sabella, F.P., Right-sided infective endocarditis with acquired tricuspid valve stenosis associated with transvenous pacemaker: a case report. Pacing Clin Electrophysiol 14 (1991), 1093–1097.
61. 61 Zager, J., Berberich, S.N., Eslava, R., Klieman, C., Dynamic tricuspid valve insufficiency produced by a right ventricular thrombus from a pacemaker. Chest 74 (1978), 455–456.
62. 62 Athan, E., Chu, V.H., Tattevin, P., et al., ICE-PCS Investigators. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307 (2012), 1727–1735.
63. 63 Iezzi, F., Cini, R., Sordini, P., Tricuspid-valve repair for pacemaker leads endocarditis. BMJ Case Rep, 2010, 2010 bcr0120102673.
64. 64 Byrd, C.L., Wilkoff, B.L., Love, C.J., et al. Intravascular extraction of problematic or infected permanent pacemaker leads: 1994–1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol 22 (1999), 1348–1357.
65. 65 Fanari, Z., Hammami, S., Hammami, M.B., Hammami, S., Shuraih, M., The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol 48 (2015), 791–797.
66. 66 Alizadeh, A., Sanati, H.R., Haji-Karimi, M., et al. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing. Europace 13 (2011), 1587–1590.
67. 67 Saito, M., Iannaccone, A., Kaye, G., et al., PROTECT-PACE Investigators. Effect of right ventricular pacing on right ventricular mechanics and tricuspid regurgitation in patients with high-grade atrioventricular block and sinus rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing Study). Am J Cardiol 116 (2015), 1875–1882.
68. 68 Sadreddini, M., Haroun, M.J., Buikema, L., et al. Tricuspid valve regurgitation following temporary or permanent endocardial lead insertion, and the impact of cardiac resynchronization therapy. Open Cardiovasc Med J 8 (2014), 113–120.
69. 69 Vaturi, M., Kusniec, J., Shapira, Y., et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr 11 (2010), 550–553.
70. 70 Fadel, B.M., Almulla, K., Husain, A., Dahdouh, Z., Di Salvo, G., Mohty, D., Spectral Doppler of the hepatic veins in tricuspid valve disease. Echocardiography 32 (2015), 856–859.
71. 71 Mediratta, A., Addetia, K., Yamat, M., et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. J Am Coll Cardiol Img 7 (2014), 337–347.
72. 72 Nucifora, G., Badano, L.P., Allocca, G., et al. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography. Echocardiography 24 (2007), 649–652.
73. 73 Narayan, R.L., Vaishnava, P., Goldman, M., Three-dimensional transthoracic echocardiography in the diagnosis of device lead-related tricuspid leaflet entrapment. Tex Heart Inst J 39 (2012), 906–907.
74. 74 Chen, T.E., Wang, C.C., Chern, M.S., Chu, J.J., Entrapment of permanent pacemaker lead as the cause of tricuspid regurgitation. Circ J 71 (2007), 1169–1171.
75. 75 Miglioranza, M.H., Becker, D., Jiménez-Nácher, J.J., Moya, J.L., Golfin, C.F., Zamorano, J.L., A new view of an unusual pacemaker complication: role of three-dimensional transthoracic echocardiography. Echocardiography 30 (2013), E164–E166.
76. 76 Cheng, Y., Gao, H., Tang, L., Li, J., Yao, L., Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads. Echocardiography 33 (2016), 1689–1696.
77. 77 Addetia, K., Maffessanti, F., Mediratta, A., et al. Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. J Am Soc Echocardiogr 27 (2014), 1164–1175.
78. 78 Champagne, J., Poirier, P., Dumesnil, J.G., et al. Permanent pacemaker lead entrapment: role of the transesophageal echocardiography. Pacing Clin Electrophysiol 25 (2002), 1131–1134.
79. 79 Tamai, R., Hara, T., Yamada, H., et al. Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography. J Med Ultrason (2001) 41 (2014), 69–71.
80. 80 Ren, J.F., Callans, D.J., Marchlinski, F.E., Tricuspid regurgitation severity associated with positioning of RV lead or other etiology assessed by intracardiac echocardiography. J Am Coll Cardiol Img 7 (2014), 1285–1286.
81. 81 Voigt, A., Shalaby, A., Saba, S., Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 33 (2010), 414–419.
82. 82 Maytin, M., Daily, T.P., Carillo, R.G., Virtual reality lead extraction as a method for training new physicians: a pilot study. Pacing Clin Electrophysiol 38 (2015), 319–325.
83. 83 Di Monaco, A., Pelargonio, G., Narducci, M.L., et al. Safety of transvenous lead extraction according to centre volume: a systematic review and meta-analysis. Europace 16 (2014), 1496–1507.
84. 84 Givon, A., Vedernikova, N., Luria, D., et al. Tricuspid regurgitation following lead extraction: risk factors and clinical course. Isr Med Assoc J 18 (2016), 18–22.
85. 85 Mehrotra, D., Kejriwal, N.K., Tricuspid valve repair for torrential tricuspid regurgitation after permanent pacemaker lead extraction. Tex Heart Inst J 38 (2011), 305–307.
86. 86 Franceschi, F., Thuny, F., Giorgi, R., et al. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol 53 (2009), 2168–2174.
87. 87 Assayag, P., Thuaire, C., Benamer, H., Sebbah, J., Leport, C., Brochet, E., Partial rupture of the tricuspid valve after extraction of permanent pacemaker leads: detection by transesophageal echocardiography. Pacing Clin Electrophysiol 22 (1999), 971–974.
88. 88 Rodriguez, Y., Mesa, J., Arguelles, E., Carrillo, R.G., Tricuspid insufficiency after laser lead extraction. Pacing Clin Electrophysiol 36 (2013), 939–944.
89. 89 Coffey, J.O., Sager, S.J., Gangireddy, S., Levine, A., Viles-Gonzalez, J.F., Fischer, A., The impact of transvenous lead extraction on tricuspid valve function. Pacing Clin Electrophysiol 37 (2014), 19–24.
90. 90 Wilkoff, B.L., Byrd, C.L., Love, C.J., et al. Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol 33 (1999), 1671–1676.
91. 91 Roeffel, S., Bracke, F., Meijer, A., et al. Transesophageal echocardiographic evaluation of tricuspid valve regurgitation during pacemaker and implantable cardioverter defibrillator lead extraction. Pacing Clin Electrophysiol 25 (2002), 1583–1586.
92. 92 Uehara, K., Minakata, K., Watanabe, K., et al. Tricuspid valve repair for severe tricuspid regurgitation due to pacemaker leads. Asian Cardiovasc Thorac Ann 24 (2016), 541–545.
93. 93 Yoshikai, M., Miho, T., Satoh, H., Nakanishi, H., Tricuspid valve replacement preserving endocardial pacemaker lead. J Card Surg 31 (2016), 311–314.
94. 94 Raman, J., Sugeng, L., Lai, D.T., Jeevanandam, V., Complex tricuspid valve repair in patients with pacer defibrillator-related tricuspid regurgitation. Ann Thorac Surg 101 (2016), 1599–1601.
95. 95 Pfannmueller, B., Hirnle, G., Seeburger, J., et al. Tricuspid valve repair in the presence of a permanent ventricular pacemaker lead. Eur J Cardiothorac Surg 39 (2011), 657–661.
96. 96 Molina, J.E., Roberts, C.L., Benditt, D.G., Long-term follow-up of permanent transvenous pacing systems preserved during tricuspid valve replacement. Ann Thorac Surg 89 (2010), 318–320.
97. 97 De Meester, P., Budts, W., Gewillig, M., Transvenous valve-in-valve replacement preserving the function of a transvalvular defibrillator lead. Catheter Cardiovasc Interv 84 (2014), 1148–1152.
98. 98 Eleid, M.F., Asirvatham, S.J., Cabalka, A.K., et al. Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads. Catheter Cardiovasc Interv 87 (2016), E160–E165.
99. 99 Paradis, J.M., Bernier, M., Houde, C., et al. Jailing of a pacemaker lead during tricuspid valve-in-valve implantation with an Edwards SAPIEN XT transcatheter heart valve. Can J Cardiol, 31, 2015 819.e9–11.
100. 100 Nazmul, M.N., Cha, Y.M., Lin, G., Asirvatham, S.J., Powell, B.D., Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Europace 15 (2013), 409–413.
101. 101 Sideris, S., Drakopoulou, M., Oikonomopoulos, G., et al. Left ventricular pacing through coronary sinus is feasible and safe for patients with prior tricuspid valve intervention. Pacing Clin Electrophysiol 39 (2016), 378–381.
102. 102 Seeburger, J., Merk, D.R., Holzhey, D., Borger, M.A., Doll, N., Mohr, F.W., The coronary sinus: a versatile option for pacemaker implantation during minimally invasive valve surgery. J Card Surg 24 (2009), 431–432.
103. 103 Yoda, M., Nakai, T., Okubo, K., et al. First case report in Japan of left ventricular pacing via a coronary vein in a patient with a mechanical tricuspid valve. Circ J 72 (2008), 335–336.
104. 104 Wilkoff, B.L., Love, C.J., Byrd, C.L., et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 6 (2009), 1085–1104.
105. 105 McLeod, C.J., Attenhofer Jost, C.H., Warnes, C.A., et al. Epicardial versus endocardial permanent pacing in adults with congenital heart disease. J Interv Card Electrophysiol 28 (2010), 235–243.
106. 106 Lau, K.C., Gaynor, J.W., Fuller, S.M., Smoots, K.A., Shah, M.J., Long-term atrial and ventricular epicardial pacemaker lead survival after cardiac operations in pediatric patients with congenital heart disease. Heart Rhythm 12 (2015), 566–573.
107. 107 Scherlag, B.J., Kosowsky, B.D., Damato, A.N., A technique for ventricular pacing from the His bundle of the intact heart. J Appl Physiol 22 (1967), 584–587.
108. 108 Deshmukh, P., Casavant, D.A., Romanyshyn, M., Anderson, K., Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 101 (2000), 869–877.
109. 109 Lustgarten, D.L., Calame, S., Crespo, E.M., Calame, J., Lobel, R., Spector, P.S., Electrical resynchronization induced by direct His-bundle pacing. Heart Rhythm 7 (2010), 15–21.
110. 110 Barba-Pichardo, R., Moriña-Vázquez, P., Fernández-Gómez, J.M., Venegas-Gamero, J., Herrera-Carranza, M., Permanent His-bundle pacing: seeking physiological ventricular pacing. Europace 12 (2010), 527–533.
111. 111 Kronborg, M.B., Mortensen, P.T., Poulsen, S.H., Gerdes, J.C., Jensen, H.K., Nielsen, J.C., His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace 16 (2014), 1189–1196.
112. 112 Zanon, F., Svetlich, C., Occhetta, E., et al. Safety and performance of a system specifically designed for selective site pacing. Pacing Clin Electrophysiol 34 (2011), 339–347.
113. 113 Sharma, P.S., Dandamudi, G., Naperkowski, A., et al. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm 12 (2015), 305–312.
114. 114 Vijayaraman, P., Dandamudi, G., Worsnick, S., Ellenbogen, K.A., Acute His-bundle injury current during permanent His-bundle pacing predicts excellent pacing outcomes. Pacing Clin Electrophysiol 38 (2015), 540–546.
115. 115 Mulpuru, S.K., Cha, Y.M., Asirvatham, S.J., Synchronous ventricular pacing with direct capture of the atrioventricular conduction system: functional anatomy, terminology, and challenges. Heart Rhythm 13 (2016), 2237–2246.
116. 116 Reddy, V.Y., Exner, D.V., Cantillon, D.J., et al., LEADLESS II Study Investigators. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med 373 (2015), 1125–1135.
117. 117 Reynolds, D.W., Ritter, P., A leadless intracardiac transcatheter pacing system. N Engl J Med 374 (2016), 2604–2605.
118. 118 Kirkfeldt, R.E., Johansen, J.B., Nohr, E.A., Jørgensen, O.D., Nielsen, J.C., Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 35 (2014), 1186–1194.